Microbot Medical's LIBERTY system featured at ISET; gains commercial traction in limited market release

Microbot Medical Inc.

LIBERTY Endovascular Robotic System highlighted at ISET conference Feb 9-12, 2026 in Miami Beach.
LIBERTY is only FDA-cleared single-use endovascular robotic system; featured in Town Hall session on future of robotics.
Limited market release commenced late 2025; full market release planned at SIR conference April 2026.
System used across multiple hospitals for wide range of procedure types including complex cases; interest from multiple specialties.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.